Literature DB >> 10655388

Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

H E de Melker1, F G Versteegh, M A Conyn-Van Spaendonck, L H Elvers, G A Berbers, A van Der Zee, J F Schellekens.   

Abstract

Laboratory confirmation of pertussis by culture, PCR, or detection of antibody increase in paired sera is hampered by low sensitivity in the later stages of the disease. Therefore, we investigated whether, and at which level, concentrations of immunoglobulin G (IgG) antibodies against pertussis toxin (PT), IgG-PT, in a single serum sample are indicative of active or recent pertussis. IgG-PT, measured by enzyme-linked immunosorbent assay in units per milliliter, was analyzed in 7,756 sera collected in a population-based study in The Netherlands, in the sera of 3,491 patients with at least a fourfold increase of IgG-PT, in paired sera of 89 patients with positive cultures and/or PCR results, and in the sera of 57 patients with clinically documented pertussis with a median follow-up of 1.4 years. We conclude that, independently of age, IgG-PT levels of at least 100 U/ml are diagnostic of recent or active infection with Bordetella pertussis. Such levels are present in less than 1% of the population and are reached in most pertussis patients within 4 weeks after disease onset and persist only temporarily.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655388      PMCID: PMC86208     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

Review 1.  The role of Bordetella pertussis infections in adults in the epidemiology of pertussis.

Authors:  J D Cherry
Journal:  Dev Biol Stand       Date:  1997

2.  Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.

Authors:  J Storsaeter; H O Hallander; L Gustafsson; P Olin
Journal:  Vaccine       Date:  1998-12       Impact factor: 3.641

3.  Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

Authors:  M Giuliano; P Mastrantonio; A Giammanco; A Piscitelli; S Salmaso; S G Wassilak
Journal:  J Pediatr       Date:  1998-06       Impact factor: 4.406

4.  Serological responses to infection with B. pertussis.

Authors:  A Giammanco; S Taormina; M Genovese; G Mangiaracina; G Giammanco; A Chiarini
Journal:  Dev Biol Stand       Date:  1997

Review 5.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

6.  Evaluation of pertussis in U.S. Marine Corps trainees.

Authors:  D L Jansen; G C Gray; S D Putnam; F Lynn; B D Meade
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

7.  The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection.

Authors:  J D Nelson
Journal:  Am J Dis Child       Date:  1978-04

8.  A serologic study of organisms possibly associated with pertussis-like coughing.

Authors:  C H Wirsing von König; H Rott; H Bogaerts; H J Schmitt
Journal:  Pediatr Infect Dis J       Date:  1998-07       Impact factor: 2.129

9.  Pertussis infection among adults during the 1993 outbreak in Chicago.

Authors:  S Rosenthal; P Strebel; P Cassiday; G Sanden; K Brusuelas; M Wharton
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

10.  Prevalence and incidence of adult pertussis in an urban population.

Authors:  M E Nennig; H R Shinefield; K M Edwards; S B Black; B H Fireman
Journal:  JAMA       Date:  1996-06-05       Impact factor: 56.272

View more
  75 in total

1.  Seroprevalence of pertussis among Danish patients with cough of unknown etiology.

Authors:  Tine Dalby; Zitta B Harboe; Karen Angeliki Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Bordetella pertussis IgG and IgA antibodies seroprevalence among 1-35 y-old population: the role of subclinical pertussis infection.

Authors:  Mohammed-Jafar Saffar; Ali-Reza Khalilian; Ali-Reza Rafee; Mohammed Reza Parsaei; Shadi Imanikhani; Jalil Shojaei; Hana Saffar
Journal:  Indian J Pediatr       Date:  2011-11-22       Impact factor: 1.967

3.  Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.

Authors:  Andrew L Baughman; Kristine M Bisgard; Kathryn M Edwards; Dalya Guris; Michael D Decker; Kathy Holland; Bruce D Meade; Freyja Lynn
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

4.  Does tetanus-diphtheria-acellular pertussis vaccination interfere with serodiagnosis of pertussis infection?

Authors:  Lucia C Pawloski; Kathryn B Kirkland; Andrew L Baughman; Monte D Martin; Elizabeth A Talbot; Nancy E Messonnier; Maria Lucia Tondella
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

5.  Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2007-05-16

6.  Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy.

Authors:  G Gabutti; M Bergamini; P Bonanni; M Guido; D Fenoglio; A Giammanco; L Sindoni; C Zotti; V Boddi; F Bamfi; R Severini; A Bechini; S Boccalini; P Crovari
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

7.  Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Authors:  Sandra L Menzies; Vijay Kadwad; Lucia C Pawloski; Tsai-Lien Lin; Andrew L Baughman; Monte Martin; Maria Lucia C Tondella; Bruce D Meade
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

8.  Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Merete Bolstad; Synne Sandbu; Hilde Bakke; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

9.  Decline of IgG pertussis toxin measured in umbilical cord blood, and neonatal and early infant serum.

Authors:  L C S Smallenburg; N A van Welie; L H Elvers; J C M van Huisseling; P F M Teunis; F G A Versteegh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-23       Impact factor: 3.267

10.  Severe and unrecognised: pertussis in UK infants.

Authors:  N S Crowcroft; R Booy; T Harrison; L Spicer; J Britto; Q Mok; P Heath; I Murdoch; M Zambon; R George; E Miller
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.